Evidence map›Paper›PMID 34626246›Full record

SynthesisCurrent urology reports2021

The Ascent of Artificial Intelligence in Endourology: a Systematic Review Over the Last 2 Decades.

B M Zeeshan Hameed, Milap Shah, Nithesh Naik, Bhavan Prasad Rai, Hadis Karimi, Patrick Rice, Peter Kronenberg, Bhaskar Somani

Abstract readSystematic Review
In one paragraph

Synthesis in Current urology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Theranostic roles of machine learning in clinical management of kidney stone disease.Computational and structural biotechnology journal · 2023
    Review
  12. Innovations in Kidney Stone Removal.Research and reports in urology · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

B M Zeeshan HameedDepartment of Urology, Kasturba Medical College Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.
Milap ShahDepartment of Urology, Kasturba Medical College Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.
Nithesh NaikiTRUE: International Training and Research, Uro-Oncology and Endourology, Manipal, Karnataka, India. nithesh.naik@manipal.edu.ORCID http://orcid.org/0000-0003-0356-7697
Bhavan Prasad RaiiTRUE: International Training and Research, Uro-Oncology and Endourology, Manipal, Karnataka, India.
Hadis KarimiDepartment of Pharmacy, Manipal College of Pharmaceuticals, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.
Patrick RiceDepartment of Urology, University Hospital Southampton NHS Trust, Southampton, UK.
Peter KronenbergHospital CUF Descobertas, Lisbon, Portugal.
Bhaskar SomaniDepartment of Urology, Kasturba Medical College Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewTo highlight and review the application of artificial intelligence (AI) in kidney stone disease (KSD) for diagnostics, predicting procedural outcomes, stone passage, and recurrence rates. The systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) checklist. RECENT

findingsThis review discusses the newer advancements in AI-driven management strategies, which holds great promise to provide an essential step for personalized patient care and improved decision making. AI has been used in all areas of KSD including diagnosis, for predicting treatment suitability and success, basic science, quality of life (QOL), and recurrence of stone disease. However, it is still a research-based tool and is not used universally in clinical practice. This could be due to a lack of data infrastructure needed to train the algorithms, wider applicability in all groups of patients, complexity of its use and cost involved with it. The constantly evolving literature and future research should focus more on QOL and the cost of KSD treatment and develop evidence-based AI algorithms that can be used universally, to guide urologists in the management of stone disease.

Indexed as

Kidney CalculiQuality of LifeAlgorithmsArtificial IntelligenceChecklistHumansArtificial intelligenceEndourologyESWLMachine learningPCNLUreteroscopy

Identifiers

PMID34626246
PMCPMC8502128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.